NCT02168010View on ClinicalTrials.gov

Analgecine for Treatment of Low Back Pain

PHASE3CompletedINTERVENTIONAL
Enrollment

584

Participants

Timeline

Start Date

October 31, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Low Back Pain
Interventions
DRUG

Analgecine

Analgesic drug under test

DRUG

Neurotropin

Analgesic drug as positive control

DRUG

Placebo

Blank tablet as placebo.

Trial Locations (7)

Unknown

Second Hospital of Sun Yat-sen University, Guangzhou

No.3 Hospital of Hebei Medical University, Shijiazhuang

Wuhan Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Shanghai Sixth People's Hosptial, Shanghai

Zhong Shan Hospital, Fudan University, Shanghai

Xijing Hospital, Xi'an

Tiangjin People's Hospital, Tianjin

All Listed Sponsors
lead

VanWorld Pharmaceutical (Rugao) Company Limited

INDUSTRY

NCT02168010 - Analgecine for Treatment of Low Back Pain | Biotech Hunter | Biotech Hunter